Trial NCT05208840

View at ClinicalTrials.gov 
Org. Study IDs: ML42302

Last trial update was posted on 2024-01-23

MeSH Interventions

Ocrelizumab

MeSH Conditions

Inflammation Multiple Sclerosis Sclerosis

Other Conditions


Stopping Reasons

Due to deterioration of the geopolitical situation and escalation of conflict between Russia and Ukraine ML42302 study was put on hold.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID